Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion
Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated ...
What's Going On With Ginkgo Bioworks Stock This Week?
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at ...
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein ...
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery ...
TMCnet1d
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
The Functional Genomics product, the flagship offering under Ginkgo Datapoints, available now, delivers large-scale ...
bovnews1d
Ginkgo Bioworks Holdings Inc (DNA) Stock Trading Recap
Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $6.81 which represents a slight increase of $0.58 or 9.31% from the prior close of $6.23. The stock opened at $6.37 and ...